TGF‐β is a very potent immunosuppressant; long‐term systematic blockage of TGF‐β may result in autoimmunity in patients; therefore, it is critical to find the delicate balance between tumor immunity and autoimmunity maintained by Tregs cells in treating tumors. The gene discussed is TGFB1; the disease is Autoimmunity.